Aller au contenu principal
Profil bibliographique

Matthew Dugan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

14Publications signalées
2630Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Hepatocellular Carcinoma Treatment and PrognosisPancreatic and Hepatic Oncology ResearchNeuroendocrine Tumor Research AdvancesCancer Treatment and PharmacologyUrbanization and City Planning

Les publications récentes

2023 article OpenAlex

Improved Overall Survival of Patients with Pancreatic Cancer through Multiagent Chemotherapy and Increased Rates of Surgical Resection

Laura M. Nicolais, Abdimajid Mohamed, Dougald C. MacGillivray, Nicholas Peter Verdini et autres

Background Seminal trials have demonstrated improved survival in pancreatic adenocarcinoma with novel multiagent chemotherapy regimens. To understand the clinical ramifications of this paradigm shift, we reviewed our institutional experience. Methods This retrospective cohort study utilized a prospective database at a single institution …

us (code pays fourni par la source)

0 citations The American Surgeon
Accès ouvert 2015 article OpenAlex

Planning the City in the New Economy: Comprehensive Planning in Austin, Texas

Gregory Claxton, Larry Schooler, Matthew Dugan

Austin, TX, exemplifies many challenges in planning for fast-growing Sun Belt cities. The process to create the recently adopted Imagine Austin Comprehensive Plan shows the difficulty in matching the tools of traditional comprehensive plans with interrelated New Economy issues and best practices …

0 citations Carolina Digital Repository (University of North Carolina at Chapel Hill)
2007 article OpenAlex

Quality of Life after High Dose Chemotherapy with Autologous Hematopoietic Progenitor Cell Support Long Term Follow-Up.

Marylou Nesbitt, Kenneth A. Ault, Fred Aronson, Marjorie A. Boyd et autres

Abstract Background: High Dose Chemotherapy with Autologous Hematopoietic Progenitor Cell Support (HDC/AutHPCS) is a cancer treatment which provides potential for improved survival and risk for short and long term treatment side effects. Self report of QOL outcomes can guide risk assessment and …

us (code pays fourni par la source)

0 citations Blood
Accès ouvert 2007 article OpenAlex

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

Marshall R. Posner, Diane M. Hershock, C. Blajman, E. Mickiewicz et autres

BACKGROUND: A randomized phase 3 trial of the treatment of squamous-cell carcinoma of the head and neck compared induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) with cisplatin and fluorouracil (PF), followed by chemoradiotherapy. METHODS: We randomly assigned 501 patients (all …

us, ca, ru, in (code pays fourni par la source)

1713 citations New England Journal of Medicine
2005 article OpenAlex

Phase I/II Trial of Paclitaxel and Vinorelbine in Advanced Non-Small Cell Lung Cancer

Steven M. Grunberg, Matthew Dugan, Marc S. Greenblatt, David Ospina et autres

Chemotherapeutic combination regimens for advanced non-small cell lung cancer traditionally have been based on platin compounds. However, a mechanistic rationale could lead to effective non-platin combinations. Paclitaxel and vinorelbine are antimicrotubule agents with different mechanisms of action, both of which have single …

us (code pays fourni par la source)

1 citation Cancer Investigation

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.